{"product_id":"hp6a-1500","title":"HPV6 L1 Capsid Antigen, Recombinant","description":"\u003cp\u003eProtein produced in genetically engineered yeast cells. This antigen has been purified by sequential chromatography. It covers Met 1 to AR6500.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 56 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Over 90% pure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -80°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -80°C. This antigen may have a tendency to self assemble, forming large aggregated particles.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.4 mg\/mL in 200 mM Sodium Citrate; 10 mM mg2Cl; 0.2% thioglycerol; 0.05% Tween 80 (pH 7.5)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReferences:\u003cbr\u003e\u003cbr\u003e\u003c\/strong\u003e1. Magensee, et al, Journal of Virol, 1993, vol 67, 315.\u003cbr\u003e2. Carter, et al, Virology, 1994, vol 199, 284.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HP6A-1500_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"50 µg","offer_id":52518878150958,"sku":"HP6A-1500-4","price":295.0,"currency_code":"USD","in_stock":false},{"title":"100 µg","offer_id":52518878183726,"sku":"HP6A-1500-5","price":495.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hp6a-1500-50ug.png?v=1788008495","url":"https:\/\/www.australbiologicals.com\/products\/hp6a-1500","provider":"Austral Biologicals","version":"1.0","type":"link"}